21 February 2022 : Clinical Research
Effect of Shengbai Decoction on Chemotherapy-Induced Myelosuppression and Survival of Gastric Cancer Patients After Radical Resection: A Retrospective Study
Linhua Yao1ABCEF, Wenming Feng2ABEF, Yulong Tao2ABCEF, Chengwu Tang2ABCDEF*DOI: 10.12659/MSM.935936
Med Sci Monit 2022; 28:e935936
Table 2 Patient characteristics.
Control group (n=58) | SD group (n=57) | P value | |
---|---|---|---|
Age (year) | 55.24±6.28 | 54.36±6.12 | 0.4483 |
Tumor size (cm) | 3.57±1.13 | 3.61±1.25 | 0.8574 |
Gender | 0.7344 | ||
Male | 39 | 40 | |
Female | 19 | 17 | |
Tumor Stage | 0.7694 | ||
II | 26 | 24 | |
III | 32 | 33 | |
Tumor differentiation | 0.9284 | ||
Well | 8 | 9 | |
Moderately | 18 | 16 | |
Poorly | 27 | 26 | |
Signet ring cell | 5 | 6 | |
Tumor location | 0.9642 | ||
Lower | 28 | 27 | |
Middle | 12 | 15 | |
Upper | 14 | 12 | |
Entire | 4 | 3 | |
Regimen of chemotherapy | 0.8550 | ||
SOX | 18 | 15 | |
CapOX | 22 | 23 | |
FOLFOX4 | 18 | 19 | |
Underlying diseases | |||
Cardiovascular disease | 5 | 7 | 0.5209 |
Respiratory disease | 6 | 8 | 0.5451 |
Diabetes | 7 | 7 | 0.9723 |